These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 23664135)
1. Cell type-specific function of TAK1 in innate immune signaling. Ajibade AA; Wang HY; Wang RF Trends Immunol; 2013 Jul; 34(7):307-16. PubMed ID: 23664135 [TBL] [Abstract][Full Text] [Related]
2. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1. Kumar M; Makonchuk DY; Li H; Mittal A; Kumar A J Immunol; 2009 Feb; 182(4):2439-48. PubMed ID: 19201899 [TBL] [Abstract][Full Text] [Related]
3. TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Ajibade AA; Wang Q; Cui J; Zou J; Xia X; Wang M; Tong Y; Hui W; Liu D; Su B; Wang HY; Wang RF Immunity; 2012 Jan; 36(1):43-54. PubMed ID: 22226633 [TBL] [Abstract][Full Text] [Related]
4. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling. Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202 [TBL] [Abstract][Full Text] [Related]
5. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917 [TBL] [Abstract][Full Text] [Related]
6. TAK1 knockdown enhances lipopolysaccharide-induced secretion of proinflammatory cytokines in myeloid cells via unleashing MEKK3 activity. Li K; Wang M; Hu Y; Xu N; Yu Q; Wang Q Cell Immunol; 2016 Dec; 310():193-198. PubMed ID: 27671672 [TBL] [Abstract][Full Text] [Related]
7. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes. Ear T; Fortin CF; Simard FA; McDonald PP J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282 [TBL] [Abstract][Full Text] [Related]
8. Targeting of TAK1 in inflammatory disorders and cancer. Sakurai H Trends Pharmacol Sci; 2012 Oct; 33(10):522-30. PubMed ID: 22795313 [TBL] [Abstract][Full Text] [Related]
9. Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells. Haase R; Richter K; Pfaffinger G; Courtois G; Ruckdeschel K J Immunol; 2005 Dec; 175(12):8209-17. PubMed ID: 16339560 [TBL] [Abstract][Full Text] [Related]
10. TAK1, more than just innate immunity. Dai L; Aye Thu C; Liu XY; Xi J; Cheung PC IUBMB Life; 2012 Oct; 64(10):825-34. PubMed ID: 22941947 [TBL] [Abstract][Full Text] [Related]
11. TAK1-JNK axis mediates survival signal through Mcl1 stabilization in activated T cells. Hirata Y; Sugie A; Matsuda A; Matsuda S; Koyasu S J Immunol; 2013 May; 190(9):4621-6. PubMed ID: 23547112 [TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling. Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863 [TBL] [Abstract][Full Text] [Related]
13. TAK1 regulates hepatic cell survival and carcinogenesis. Roh YS; Song J; Seki E J Gastroenterol; 2014 Feb; 49(2):185-94. PubMed ID: 24443058 [TBL] [Abstract][Full Text] [Related]
14. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. Mochida Y; Takeda K; Saitoh M; Nishitoh H; Amagasa T; Ninomiya-Tsuji J; Matsumoto K; Ichijo H J Biol Chem; 2000 Oct; 275(42):32747-52. PubMed ID: 10921914 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Wang Y; Huang G; Vogel P; Neale G; Reizis B; Chi H Proc Natl Acad Sci U S A; 2012 Feb; 109(6):E343-52. PubMed ID: 22308391 [TBL] [Abstract][Full Text] [Related]
16. CPEB regulation of TAK1 synthesis mediates cytokine production and the inflammatory immune response. Ivshina M; Alexandrov IM; Vertii A; Doxsey S; Richter JD Mol Cell Biol; 2015 Feb; 35(3):610-8. PubMed ID: 25452303 [TBL] [Abstract][Full Text] [Related]
17. Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1. Hong CS; Park MR; Sun EG; Choi W; Hwang JE; Bae WK; Rhee JH; Cho SH; Chung IJ Front Immunol; 2019; 10():1760. PubMed ID: 31402917 [TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling. Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169 [TBL] [Abstract][Full Text] [Related]
19. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy. Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973 [TBL] [Abstract][Full Text] [Related]